Status:
RECRUITING
Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Cancer
Lymphatic Metastasis
Eligibility:
All Genders
Brief Summary
The goal of this diagnostic test is to develop an artificial intelligence (AI)-based pan-cancer universal diagnostic model for detecting pathological lymph node metastasis (LNM), and prospectively eva...
Detailed Description
Lymph node metastasis (LNM) is a common mode of cancer metastasis, and accurate postoperative pathological lymph node staging is of great significance for further treatment and prognosis assessment. H...
Eligibility Criteria
Inclusion
- Patients with cancer, undergoing radical tumor resection and lymph node dissection.
- Patients with complete clinical and pathological information.
Exclusion
- The patient refused to participate in this diagnostic test.
Key Trial Info
Start Date :
July 26 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06517979
Start Date
July 26 2024
End Date
June 30 2027
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China, 510120